Regulation of cAMP dynamics by Ca2+ and G protein-coupled receptors in the pancreatic β-cell: a computational approach
Open Access
- 1 December 2007
- journal article
- Published by American Physiological Society in American Journal of Physiology-Cell Physiology
- Vol. 293 (6) , C1924-C1933
- https://doi.org/10.1152/ajpcell.00555.2006
Abstract
In this report we describe a mathematical model for the regulation of cAMP dynamics in pancreatic β-cells. Incretin hormones such as glucagon-like peptide 1 (GLP-1) increase cAMP and augment insulin secretion in pancreatic β-cells. Imaging experiments performed in MIN6 insulinoma cells expressing a genetically encoded cAMP biosensor and loaded with fura-2, a calcium indicator, showed that cAMP oscillations are differentially regulated by periodic changes in membrane potential and GLP-1. We modeled the interplay of intracellular calcium (Ca2+) and its interaction with calmodulin, G protein-coupled receptor activation, adenylyl cyclases (AC), and phosphodiesterases (PDE). Simulations with the model demonstrate that cAMP oscillations are coupled to cytoplasmic Ca2+ oscillations in the β-cell. Slow Ca2+ oscillations (3–4 min−1) entrain high-frequency, low-amplitude cAMP oscillations. The model predicts that GLP-1 receptor agonists induce cAMP oscillations in phase with cytoplasmic Ca2+ oscillations. In contrast, observed antiphasic Ca2+ and cAMP oscillations can be simulated following combined glucose and tetraethylammonium-induced changes in membrane potential. The model provides additional evidence for a pivotal role for Ca2+-dependent AC and PDE activation in coupling of Ca2+ and cAMP signals. Our results reveal important differences in the effects of glucose/TEA and GLP-1 on cAMP dynamics in MIN6 β-cells.Keywords
This publication has 44 references indexed in Scilit:
- cAMP sensor Epac as a determinant of ATP‐sensitive potassium channel activity in human pancreatic β cells and rat INS‐1 cellsThe Journal of Physiology, 2006
- Adenine nucleotide regulation in pancreatic β-cells: modeling of ATP/ADP-Ca2+interactionsAmerican Journal of Physiology-Endocrinology and Metabolism, 2005
- Ca2+-calmodulin-dependent phosphodiesterase (PDE1): Current perspectivesCellular Signalling, 2005
- Targeting β-cell cyclic 3′5′adenosine monophosphate for the development of novel drugs for treating type 2 diabetes mellitus. A reviewJournal of Pharmacy and Pharmacology, 2004
- Glucagon‐Like Peptide‐1: Regulation of Insulin Secretion and Therapeutic PotentialBasic & Clinical Pharmacology & Toxicology, 2004
- Sustained Entry of Ca2+ Is Required to Activate Ca2+-Calmodulin-dependent Phosphodiesterase 1APublished by Elsevier ,2004
- Periodic Signaling Controlled by an Oscillatory Circuit That Includes Protein Kinases ERK2 and PKAScience, 2004
- Modeling Interactions Between Electrical Activity and Second-Messenger Cascades inAplysiaNeuron R15Journal of Neurophysiology, 2004
- Important Role of Phosphodiesterase 3B for the Stimulatory Action of cAMP on Pancreatic β-Cell Exocytosis and Release of InsulinJournal of Biological Chemistry, 2002
- Expression of Adenylyl Cyclase Subtypes in Pancreatic β-CellsBiochemical and Biophysical Research Communications, 1999